Stem cell-based islet replacement therapy in diabetes: A road trip that reached the clinic
- PMID: 34861145
- DOI: 10.1016/j.stem.2021.11.008
Stem cell-based islet replacement therapy in diabetes: A road trip that reached the clinic
Abstract
One hundred years after the discovery of insulin, Kieffer and colleagues (Ramzy et al., 2021) and Foyt and colleagues (Shapiro et al., 2021) report interim results from a multicenter clinical trial showing insulin secretion from engrafted pluripotent stem cell-derived endocrine progenitor cells in patients with type 1 diabetes.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests E.J.P.d.K. is councillor of the International Pancreas and Islet Transplantation Association and immediate past president of the European Pancreas and Islet Transplantation Association. E.J.P.d.K. has served as a consultant to Evotec.
Comment on
-
Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes.Cell Stem Cell. 2021 Dec 2;28(12):2047-2061.e5. doi: 10.1016/j.stem.2021.10.003. Cell Stem Cell. 2021. PMID: 34861146 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical